We have a revolutionary wound care program that was developed over an eighteen-month period by consulting with 73 Podiatrists. The program addresses the challenges, pitfalls, increased patient outcomes and increasing the profitability of the practice.
WOUND CARE PROGRAM
Progress Medical provides an end to end solution for wound care providers through our partner BioLab Sciences.
The flagship product developed is Dermistat which is a painless, non-surgical procedure which leverages a small sample of a patient’s own skin to produce partial thickness skin grafts in two days. This is the only 100% autologous skin graft on the market of its type with a Q code. We also have an amniotic liquid allograft and an amniotic dual membrane allograft both of which are supported with Q codes.
Causes for wounds: Poor Circulation, Diabetes, Lymphedema, Smoking, Venous Insufficiency, Hypertension, Inflammatory Disease, & other medical conditions.
Click Below to enlarge
POLYMERASE CHAIN REACTION (PCR)
Wound (Bacterial/Fungal) –
One simple swab collection provides fast, definitive identification of targeted pathogens.
• Faster and more specific diagnosis leads to faster healing
• Therapeutic recommendations provided with each report via our in-house
• Targets key Bacterial, Viral, and Fungal Pathogens
This genetic test is able to detect anaerobic organisms growing deep inside a wound that a standard culture would often miss. You can expect a fast turnaround on the final report and detailed accuracy with this test.
NFI – Nail/fungal Infection –
Fungal nail polymerase chain reaction (PCR) technology is a real time molecular DNA test that has analyzed more than 1.6 million cases of nail dystrophy. This technology produces results within 24 to 48 hours, in comparison with other tests for fungal nail culture, which can take several weeks for results.
Physicians can use the DNA test to detect 15 different genera or species of fungal pathogens that cause onychomycosis, including dermatophytes, saprophytes and/or yeast. The system can also diagnose pathologies that may mimic dermatophyte nail infection, including psoriasis, lichen planus or trauma. DNA assay allows physicians to deliver to patients a comprehensive evaluation of nail unit dystrophy and then determine the proper therapy for the underlying problem.